What does CUSIP 230770109 represent in this 13F holders report?

CUSIP 230770109 is the security identifier for CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock used to aggregate holder disclosures.

How many institutions held CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in Q3 2025?

30 institutional investors reported CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock for Q3 2025. Use the holders table for investor-level position and value details.

CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)

CUSIP: 230770109

Q3 2025 13F Holders as of 30 Sep 2025

Security type / class: Equity / Common stock
Total 13F shares: 3,406,057
Total 13F value: $10,626,381
Share change: -275,213
Put/Call ratio: 86%
SEC-reported price per share: $3.12
Number of holders: 30
Value change: -$866,501
Number of buys: 9
Number of sells: 16
Shares outstanding: 15,075,924

Security key

230770109

Report period

Q3 2025

Institutions

Top holders

CPIX full security history Ownership snapshot Full 13F holder table CUMBERLAND PHARMACEUTICALS INC SEC filings CUMBERLAND PHARMACEUTICALS INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Ikarian Capital, LLC

Disclosed value leader

Ikarian Capital, LLC

Comparable rows

15/15

Latest evidence

30 Sep 2025

13D/G 13F Lead comparable stake: 4.9% 13D/G row: Ikarian Capital, LLC Showing 1-6 of 15 holder rows.

Quick read

Ikarian Capital, LLC leads the comparable SEC ownership view at 4.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Ikarian Capital, LLC's linked filing trail.

Comparable ownership Top 5

Ikarian Capital, LLC 4.9%

INTEGRATED CORE STRATEGIES (US) LLC 4%

MILLENNIUM MANAGEMENT LLC 5.1%

RENAISSANCE TECHNOLOGIES LLC 3.3%

VANGUARD GROUP INC 2.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Ikarian Capital, LLC	13D/G 13F Company 13D/G 13F	4.9%	$3,545,020 730,932 shares	$0	31 Mar 2025
INTEGRATED CORE STRATEGIES (US) LLC	13D/G 13D/G	4%	$1,618,467 598,634 shares	-$571,171	30 Sep 2025
MILLENNIUM MANAGEMENT LLC	13F Company 13F	5.1%	$2,599,520 775,976 shares	—	30 Jun 2025
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	3.3%	$1,658,126 494,963 shares	—	30 Jun 2025
VANGUARD GROUP INC	13F Company 13F	2.7%	$1,379,483 411,786 shares	—	30 Jun 2025
DIMENSIONAL FUND ADVISORS LP	13F Company 13F	1.7%	$847,178 252,889 shares	—	30 Jun 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,406,057

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

Q3 2025 holders

Holder diff

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 value	Q3 2025 value	Value change	Value Chg %